PKM and cholangiocarcinoma: PKM2 in human bile can be utilized to identify malignant biliary stenosis, but it fails to distinguish CCA from other malignant biliary diseases, and its low diagnostic sensitivity restricts the ability to serve as a diagnostic biomarker [11].